To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The funding round brings ...
The next four patients will receive a higher dose of LyGenesis's cell therapy to grow functioning liver tissue in patients with end stage liver disease PITTSBURGH, March 4, 2025 /PRNewswire/ -- ...
A person has received an experimental treatment for the first time that, if successful, will lead them to grow an additional ‘miniature liver’. The procedure, developed by the biotechnology firm ...
For the first time, scientists are attempting to grow a new, miniature liver inside of a person. It sounds like science fiction; in fact, the idea was the plot of a Grey’s Anatomy episode that aired ...
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately held ...
PITTSBURGH, Oct. 21, 2019 /PRNewswire/ -- LyGenesis, Inc., a biotechnology company focused on organ regeneration, announced today that they have completed a total of $4 million in private financing of ...
Lygenesis Inc. and Imagine Pharma Inc. have entered into a joint research collaboration to develop novel cell therapies for patients with type 1 diabetes. The collaboration will leverage Imagine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results